Similarly to studies in other solid cancers, we found that the expression of LITAF was downregulated in most of pancreatic cancer cases (76%, 19/25); most of them were pancreatic ductal adenocarcinoma. The gene discussed is LITAF; the disease is pancreatic ductal adenocarcinoma.